Non-Opioid Pain Management Solutions in Phoenix, AZ

non opioid pain management for a city of 1M+ — without a fake storefront

If a sales sheet cannot tell you that Phoenix is JF (Noridian Healthcare Solutions) and that adult diabetes here is 10.8% (PLACES 2023), it is selling units, not a program. That is the non opioid pain management conversation we actually have.

The chart problems we still see in AZ

• Adult arthritis here is 21.3% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 17.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Arizona.
• Arizona is outside CDC's historical Diabetes Belt core, but the national 12% diabetes figure still applies as a planning baseline until a clinic uses its own payer mix. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).
• AHR’s BRFSS diabetes range (Colorado 8.4% to West Virginia 18.4%) is state-level, not city-level. We will not invent a Phoenix-specific diabetes rate. Plan from CDC national 12% plus your panel.

Arizona Department of Health Services vs. the IFU

17.3% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. A city of 1M+ with 1,608,139 residents will still mix those payers. CDC PLACES (2023, crude) estimates 10.8% of adults in Phoenix have diagnosed diabetes — 1.2 points below the U.S. 12% figure. Build two utilization policies if you do both cash PRP and Medicare CTPs.

A practical checklist for Phoenix